Discordance between PAM50 intrinsic subtyping and immunohistochemistry in South African women with breast cancer
Open Access
- 3 March 2023
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 199 (1) , 1-12
Abstract
Purpose: Breast cancer is a heterogeneous disease with different gene expression profiles, treatment options and outcomes. In South Africa, tumors are classified using immunohistochemistry. In high-income countries multiparameter genomic assays are being utilized with implications for tumor classification and treatment. Methods: In a cohort of 378 breast cancer patients from the SABCHO study, we investigated the concordance between tumor samples classified by IHC and the PAM50 gene assay. Results: IHC classified patients as ER-positive (77.5%), PR-positive (70.6%), and HER2-positive (32.3%). These results, together with Ki67, were used as surrogates for intrinsic subtyping, and showed 6.9% IHC-A-clinical, 72.7% IHC-B-clinical, 5.3% IHC-HER2-clinical and 15.1% triple negative cancer (TNC). Typing using the PAM50 gave 19.3% luminal-A, 32.5% luminal-B, 23.5% HER2-enriched and 24.6% basal-like. The basal-like and TNC had the highest concordance, while the luminal-A and IHC-A group had the lowest concordance. By altering the cutoff for Ki67, and realigning the HER2/ER/PR-positive patients to IHC-HER2, we improved concordance with the intrinsic subtypes. Conclusion: We suggest that the Ki67 be changed to a cutoff of 20–25% in our population to better reflect the luminal subtype classifications. This change would inform treatment options for breast cancer patients in settings where genomic assays are unaffordable.Keywords
Funding Information
- Division of Cancer Epidemiology and Genetics (01-CA192627, 01-CA192627, 01-CA192627, 01-CA192627, P30-CA136696, P30-CA136696, P30-CA136696, P30-CA136696)
- South African Medical Research Council (Common Epithelial Cancer Research Center)
- South African National Research Foundation
- University of the Witwatersrand
This publication has 50 references indexed in Scilit:
- Breast cancer receptor status and stage at diagnosis in over 1,200 consecutive public hospital patients in Soweto, South Africa: a case seriesBreast Cancer Research, 2013
- St. Gallen 2013: Brief Preliminary Summary of the Consensus DiscussionBreast Care, 2013
- PAM50 Breast Cancer Subtyping by RT-qPCR and Concordance with Standard Clinical Molecular MarkersBMC Medical Genomics, 2012
- The current state of breast cancer classificationAnnals of Oncology, 2012
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working GroupJNCI: Journal of the National Cancer Institute, 2011
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011Annals of Oncology, 2011
- Issues and updates: evaluating estrogen receptor-α, progesterone receptor, and HER2 in breast cancerLaboratory Investigation, 2010
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast CancerJNCI: Journal of the National Cancer Institute, 2009
- Oestrogen receptor status of breast carcinoma: Allred/H score conversion tableHistopathology, 2008
- Immunohistochemical and molecular subtypes of breast cancer in NigeriaBreast Cancer Research and Treatment, 2007